The burden of migraine and predictions in the Asia-Pacific region, 1990-2021: a comparative analysis of China, South Korea, Japan, and Australia
- PMID: 40329199
- PMCID: PMC12057080
- DOI: 10.1186/s10194-025-02048-6
The burden of migraine and predictions in the Asia-Pacific region, 1990-2021: a comparative analysis of China, South Korea, Japan, and Australia
Abstract
Background: Migraine is a leading cause of disability worldwide, significantly impacting quality of life and healthcare systems. Despite its high prevalence and burden, migraine remains underprioritized in global health policies. This study examines the epidemiological trends of migraine in Australia, China, Japan, and South Korea from 1990 to 2021, highlighting regional disparities and forecasting future burdens.
Methods: This study utilized data from the Global Burden of Disease (GBD) 2021 to analyze incidence, prevalence, and years lived with disability (YLDs) of migraine. Age-standardized rates (ASRs) were calculated to enable fair cross-country comparisons. Joinpoint regression analysis was applied to assess temporal trends, while Bayesian age-period-cohort (BAPC) modeling was used to project future trends until 2050. Additionally, decomposition analysis was conducted to differentiate the effects of population aging, growth, and epidemiological changes.
Results: In 2021, China had the highest migraine burden, with 13.05 million new cases and 184.75 million prevalent cases, followed by Australia, Japan, and South Korea. Incidence rates peaked in adolescence (10-14 years), while prevalence and disability were highest in middle-aged women (40-44 years). From 1990 to 2021, Australia exhibited stable trends, China experienced increasing burden, Japan saw a decline due to aging, and Korea exhibited mixed patterns influenced by opposing demographic and epidemiological forces. Future projections suggest a stable trend in Australia, declining incidence in China and Japan, and continued burden in Korea.
Conclusion: Migraine remains a significant public health challenge across all four countries, with age, gender, and demographic changes playing key roles in burden variations. The study highlights the need for region-specific healthcare strategies and age- and gender-sensitive interventions. Future research should explore socioeconomic, behavioral, and healthcare access factors to refine migraine management strategies.
Keywords: Age-period-cohort modeling; Asia–Pacific; Disability; Epidemiology; Global Burden of Disease; Migraine; Public health policy; Temporal trends.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests.
Figures


















Similar articles
-
Prevalence trend and burden of foodborne trematodiasis in China from 1990 to 2021 and its predictions until 2030: a comparative study with Japan and South Korea.Front Public Health. 2025 Feb 24;13:1504218. doi: 10.3389/fpubh.2025.1504218. eCollection 2025. Front Public Health. 2025. PMID: 40066009 Free PMC article.
-
The temporal trends of prevalence and years lived with disability of anaemia in China, Japan, and South Korea, from 1990 to 2021: Results from the Global Burden of Disease Study 2021.J Glob Health. 2024 May 24;14:04073. doi: 10.7189/jogh.14.04073. J Glob Health. 2024. PMID: 38779874 Free PMC article.
-
Disease burden and attributable risk factors of major depressive disorder in China, Japan, and South Korea from 1990 to 2021 and its prediction to 2035.Front Public Health. 2025 Apr 14;13:1510091. doi: 10.3389/fpubh.2025.1510091. eCollection 2025. Front Public Health. 2025. PMID: 40297030 Free PMC article.
-
Prevalence, burden, and clinical management of migraine in China, Japan, and South Korea: a comprehensive review of the literature.J Headache Pain. 2019 Dec 5;20(1):111. doi: 10.1186/s10194-019-1062-4. J Headache Pain. 2019. PMID: 31805851 Free PMC article. Review.
-
Global and China trends and forecasts of disease burden for female lung Cancer from 1990 to 2021: a study based on the global burden of disease 2021 database.J Cancer Res Clin Oncol. 2025 Feb 8;151(2):68. doi: 10.1007/s00432-025-06084-2. J Cancer Res Clin Oncol. 2025. PMID: 39921760 Free PMC article. Review.
Cited by
-
Migraine is a risk factor for dementia: a systematic review and meta-analysis of cohort studies.J Headache Pain. 2025 Jun 6;26(1):136. doi: 10.1186/s10194-025-02078-0. J Headache Pain. 2025. PMID: 40481389 Free PMC article. Review.
References
-
- Steiner TJ (2004) Lifting the burden: the global campaign against headache. Lancet Neurol 3(4):204–205 - PubMed
-
- Burch RC, Buse DC, Lipton RB (2019) Migraine: epidemiology, burden, and comorbidity. Neurol Clin 37(4):631–649 - PubMed
-
- GBD (2021) Diseases and Injuries Collaborators (2024) Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the global burden of disease study 2021. Lancet 403(10440):2133–2161 - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical